CVS suspends sales of Zantac brand due to contaminant fears.
CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.that some of the pills contained small amounts N-nitrosodimethylamine , which has also been found in some widely used blood pressure medicines, leading to shortages of those drugs.
CVS said the move to suspend sales of the over-the-counter heartburn drug was taken out of caution while the FDA continues to review if low levels of NDMA in ranitidine — the active ingredient in Zantac — poses a health risk to patients. "Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time,"
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
CVS suspends sales of Zantac brand and generic heartburn drug during safety reviewCVS Health Corp said on Saturday it will discontinue sales the popular Zantac he...
Weiterlesen »
CVS pulls Zantac and similar heartburn drugs because of cancer worriesCVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, over concerns that they might contain a substance that could cause cancer.
Weiterlesen »
CVS suspends sales of Zantac brand and generic heartburn drug during safety reviewCVS Health Corp said on Saturday it will discontinue sales the popular Zantac he...
Weiterlesen »